Literature DB >> 7356223

Treatment of diabetic cystopathy.

C Frimodt-Møller, S Mortensen.   

Abstract

Neurogenic bladder disorders in diabetic patients may result in insufficient bladder emptying because of loss of reflex detrusor contraction. In those who are asymptomatic or have only moderate signs of diabetic cystopathy, treatment choices are scheduled voiding by the triple-voiding technique, cholinergic treatment either daily or twice weekly, and transurethral surgery of the bladder neck. In patients with total urine retention, an indwelling catheter will decrease the overstretched detrusor muscle. Cholinergic treatment with initially high parenteral doses of bethanecol may help to diminish residual urine. Transurethral surgery is often mandatory in such cases. Decensus of the bladder in females often requires surgery. Deficient bladder sensation is irreversible in diabetics, and follow-up of treatment should be lifelong.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7356223     DOI: 10.7326/0003-4819-92-2-327

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  9 in total

1.  Human Umbilical Cord Mesenchymal Stem Cells Overexpressing Nerve Growth Factor Ameliorate Diabetic Cystopathy in Rats.

Authors:  Wu WenBo; Zhang Fei; Du YiHeng; Wang Wei; Yan TingMang; Zhou WenHao; Liu QianRu; Liu HaiTao
Journal:  Neurochem Res       Date:  2017-09-26       Impact factor: 3.996

2.  Detrusor contractility to parasympathetic mediators is differentially altered in the compensated and decompensated states of diabetic bladder dysfunction.

Authors:  Nicole S Klee; Robert S Moreland; Derek M Kendig
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-29

3.  Thermoreceptor mediated bladder sensation in patients with diabetic cystopathy.

Authors:  M Ishigooka; T Hashimoto; S Hayami; Y Suzuki; O Ichiyanagi; T Nakada
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

4.  Role of symptom scoring and uroflowmetry in patients with diabetic cystopathy.

Authors:  M Ishigooka; Y Suzuki; S Hayami; O Ichiyanagi; T Hashimoto; T Nakada
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

5.  Using gene chips to identify organ-specific, smooth muscle responses to experimental diabetes: potential applications to urological diseases.

Authors:  Jason D Hipp; Kelvin P Davies; Moses Tar; Mira Valcic; Abraham Knoll; Arnold Melman; George J Christ
Journal:  BJU Int       Date:  2007-02       Impact factor: 5.588

Review 6.  Diagnosis and treatment of diabetic autonomic neuropathy.

Authors:  D Ziegler
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

7.  Bladder dysfunction in diabetes mellitus.

Authors:  Saeid Golbidi; Ismail Laher
Journal:  Front Pharmacol       Date:  2010-11-16       Impact factor: 5.810

Review 8.  Autonomic neuropathy in diabetics: a review.

Authors:  J G Williams
Journal:  J R Soc Med       Date:  1983-06       Impact factor: 18.000

9.  Functional and molecular characterization of hyposensitive underactive bladder tissue and urine in streptozotocin-induced diabetic rat.

Authors:  Jayabalan Nirmal; Pradeep Tyagi; Yao-Chi Chuang; Wei-Chia Lee; Naoki Yoshimura; Chao-Cheng Huang; Bharathi Rajaganapathy; Michael B Chancellor
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.